Financhill
Sell
23

IVF Quote, Financials, Valuation and Earnings

Last price:
$0.77
Seasonality move :
10.27%
Day range:
$0.76 - $0.85
52-week range:
$0.76 - $17.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.07x
P/B ratio:
--
Volume:
174.1K
Avg. volume:
424.6K
1-year change:
-91.83%
Market cap:
$1.7M
Revenue:
$6.5M
EPS (TTM):
-$34.05

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IVF
INVO Fertility
$1.7M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies
$1.8M -- 120.4% -57.14% $1.45
NTRB
Nutriband
$665K -$0.17 59.2% -13.33% $15.00
NVNO
enVVeno Medical
-- -$0.28 -- -9.68% $12.50
SINT
SINTX Technologies
$400K -$0.79 5.82% -78.12% $28.00
XAIR
Beyond Air
$1.7M -- 155.97% -- $2.25
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IVF
INVO Fertility
$0.78 -- $1.7M -- $0.00 0% 0.07x
NMTC
NeuroOne Medical Technologies
$0.71 $1.45 $35.5M -- $0.00 0% 3.68x
NTRB
Nutriband
$7.96 $15.00 $88.6M -- $0.00 0% 36.83x
NVNO
enVVeno Medical
$4.18 $12.50 $73.3M -- $0.00 0% 407.78x
SINT
SINTX Technologies
$3.33 $28.00 $8.4M -- $0.00 0% 3.19x
XAIR
Beyond Air
$0.20 $2.25 $18.1M -- $0.00 0% 3.56x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IVF
INVO Fertility
65.97% 1.151 20.29% 0.05x
NMTC
NeuroOne Medical Technologies
-- 0.459 -- 0.93x
NTRB
Nutriband
3.43% 1.334 0.24% 3.31x
NVNO
enVVeno Medical
-- 1.389 -- --
SINT
SINTX Technologies
2.11% 1.788 1.98% 2.98x
XAIR
Beyond Air
41.93% 0.040 42.16% 1.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IVF
INVO Fertility
$592.3K -$2.5M -313.33% -714.24% -1044.01% -$3.6M
NMTC
NeuroOne Medical Technologies
$771.1K -$2.7M -281.01% -281.01% -163.76% -$59.3K
NTRB
Nutriband
$252K -$1.4M -100.04% -102.63% -207.21% -$1.3M
NVNO
enVVeno Medical
-- -$5M -- -- -- -$4M
SINT
SINTX Technologies
$45K -$2.4M -177.02% -180.99% -783.16% -$1.4M
XAIR
Beyond Air
-$32K -$7.2M -146.65% -218.07% -649.57% -$8.5M

INVO Fertility vs. Competitors

  • Which has Higher Returns IVF or NMTC?

    NeuroOne Medical Technologies has a net margin of -1063.02% compared to INVO Fertility's net margin of -163.76%. INVO Fertility's return on equity of -714.24% beat NeuroOne Medical Technologies's return on equity of -281.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
    NMTC
    NeuroOne Medical Technologies
    55.61% -$0.07 $1.1M
  • What do Analysts Say About IVF or NMTC?

    INVO Fertility has a consensus price target of --, signalling upside risk potential of 673.4%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 103.65%. Given that INVO Fertility has higher upside potential than NeuroOne Medical Technologies, analysts believe INVO Fertility is more attractive than NeuroOne Medical Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility
    0 0 0
    NMTC
    NeuroOne Medical Technologies
    1 0 0
  • Is IVF or NMTC More Risky?

    INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.052%.

  • Which is a Better Dividend Stock IVF or NMTC?

    INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or NMTC?

    INVO Fertility quarterly revenues are $1.6M, which are larger than NeuroOne Medical Technologies quarterly revenues of $1.4M. INVO Fertility's net income of -$17.4M is lower than NeuroOne Medical Technologies's net income of -$2.3M. Notably, INVO Fertility's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.07x versus 3.68x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
    NMTC
    NeuroOne Medical Technologies
    3.68x -- $1.4M -$2.3M
  • Which has Higher Returns IVF or NTRB?

    Nutriband has a net margin of -1063.02% compared to INVO Fertility's net margin of -208.09%. INVO Fertility's return on equity of -714.24% beat Nutriband's return on equity of -102.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
  • What do Analysts Say About IVF or NTRB?

    INVO Fertility has a consensus price target of --, signalling upside risk potential of 673.4%. On the other hand Nutriband has an analysts' consensus of $15.00 which suggests that it could grow by 88.44%. Given that INVO Fertility has higher upside potential than Nutriband, analysts believe INVO Fertility is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility
    0 0 0
    NTRB
    Nutriband
    1 0 0
  • Is IVF or NTRB More Risky?

    INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison Nutriband has a beta of 1.226, suggesting its more volatile than the S&P 500 by 22.565%.

  • Which is a Better Dividend Stock IVF or NTRB?

    INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or NTRB?

    INVO Fertility quarterly revenues are $1.6M, which are larger than Nutriband quarterly revenues of $667.4K. INVO Fertility's net income of -$17.4M is lower than Nutriband's net income of -$1.4M. Notably, INVO Fertility's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.07x versus 36.83x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
  • Which has Higher Returns IVF or NVNO?

    enVVeno Medical has a net margin of -1063.02% compared to INVO Fertility's net margin of --. INVO Fertility's return on equity of -714.24% beat enVVeno Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
    NVNO
    enVVeno Medical
    -- -$0.22 --
  • What do Analysts Say About IVF or NVNO?

    INVO Fertility has a consensus price target of --, signalling upside risk potential of 673.4%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 199.04%. Given that INVO Fertility has higher upside potential than enVVeno Medical, analysts believe INVO Fertility is more attractive than enVVeno Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility
    0 0 0
    NVNO
    enVVeno Medical
    1 0 0
  • Is IVF or NVNO More Risky?

    INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.932, suggesting its less volatile than the S&P 500 by 6.781%.

  • Which is a Better Dividend Stock IVF or NVNO?

    INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or NVNO?

    INVO Fertility quarterly revenues are $1.6M, which are larger than enVVeno Medical quarterly revenues of --. INVO Fertility's net income of -$17.4M is lower than enVVeno Medical's net income of -$4.5M. Notably, INVO Fertility's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.07x versus 407.78x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
    NVNO
    enVVeno Medical
    407.78x -- -- -$4.5M
  • Which has Higher Returns IVF or SINT?

    SINTX Technologies has a net margin of -1063.02% compared to INVO Fertility's net margin of -787.63%. INVO Fertility's return on equity of -714.24% beat SINTX Technologies's return on equity of -180.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
  • What do Analysts Say About IVF or SINT?

    INVO Fertility has a consensus price target of --, signalling upside risk potential of 673.4%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 740.84%. Given that SINTX Technologies has higher upside potential than INVO Fertility, analysts believe SINTX Technologies is more attractive than INVO Fertility.

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility
    0 0 0
    SINT
    SINTX Technologies
    1 0 0
  • Is IVF or SINT More Risky?

    INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.713, suggesting its less volatile than the S&P 500 by 28.749%.

  • Which is a Better Dividend Stock IVF or SINT?

    INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or SINT?

    INVO Fertility quarterly revenues are $1.6M, which are larger than SINTX Technologies quarterly revenues of $291K. INVO Fertility's net income of -$17.4M is lower than SINTX Technologies's net income of -$2.3M. Notably, INVO Fertility's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.07x versus 3.19x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
  • Which has Higher Returns IVF or XAIR?

    Beyond Air has a net margin of -1063.02% compared to INVO Fertility's net margin of -697.4%. INVO Fertility's return on equity of -714.24% beat Beyond Air's return on equity of -218.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
    XAIR
    Beyond Air
    -2.78% -$0.09 $24.1M
  • What do Analysts Say About IVF or XAIR?

    INVO Fertility has a consensus price target of --, signalling upside risk potential of 673.4%. On the other hand Beyond Air has an analysts' consensus of $2.25 which suggests that it could grow by 1053.85%. Given that Beyond Air has higher upside potential than INVO Fertility, analysts believe Beyond Air is more attractive than INVO Fertility.

    Company Buy Ratings Hold Ratings Sell Ratings
    IVF
    INVO Fertility
    0 0 0
    XAIR
    Beyond Air
    2 1 0
  • Is IVF or XAIR More Risky?

    INVO Fertility has a beta of 2.045, which suggesting that the stock is 104.471% more volatile than S&P 500. In comparison Beyond Air has a beta of 0.221, suggesting its less volatile than the S&P 500 by 77.879%.

  • Which is a Better Dividend Stock IVF or XAIR?

    INVO Fertility has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. INVO Fertility pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IVF or XAIR?

    INVO Fertility quarterly revenues are $1.6M, which are larger than Beyond Air quarterly revenues of $1.2M. INVO Fertility's net income of -$17.4M is lower than Beyond Air's net income of -$8M. Notably, INVO Fertility's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for INVO Fertility is 0.07x versus 3.56x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
    XAIR
    Beyond Air
    3.56x -- $1.2M -$8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Can FUBO Stock Double?
Can FUBO Stock Double?

TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock